DAVID S. WICHMANN - 21 May 2025 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Director
Signature
/s/ Anita Beth Adams, as attorney-in-fact
Issuer symbol
PRVA
Transactions as of
21 May 2025
Transactions value $
$0
Form type
4
Filing time
23 May 2025, 17:03:50 UTC
Previous filing
09 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WICHMANN DAVID S Director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE ROAD, SUITE 700, ARLINGTON /s/ Anita Beth Adams, as attorney-in-fact 23 May 2025 0001268489

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, par value $0.01 per share Award $0 +8.4K +48.5% $0.00 25.7K 21 May 2025 Direct F1
holding PRVA Common Stock, par value $0.01 per share 1.32M 21 May 2025 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
F2 Represents shares held by Jory Capital, LLC, which is co-owned by the Reporting Person.